Cagrilintide

Cagrilintide

Overview

Cagrilintide is a synthetic research peptide derived from the pancreatic hormone amylin, studied in laboratory settings for its interaction with amylin receptors and regulatory pathways associated with metabolic signaling.

Within controlled research environments, Cagrilintide has been observed for its potential influence on receptor activity, peptide stability, and signaling processes associated with appetite regulation, energy balance, and metabolic research at the cellular level.

Scientific Background

Cagrilintide is a lipidated, long-acting amylin analog designed to improve stability and extend biological activity compared to endogenous amylin. Its modified structure supports prolonged exposure and reduced susceptibility to enzymatic degradation.

In vitro studies focus on its interaction with amylin receptor complexes and related intracellular signaling pathways. Research explores Cagrilintide’s structural properties, receptor-binding activity, peptide stability, and its role in modulating amylin-related signaling under controlled laboratory conditions.

Specifications

• Molecular Formula: C194H312N54O59S2
• Molecular Weight: Approximately 4,409.1 g/mol
• Peptide Type: Lipidated long-acting amylin analog
• Purity: ≥99%
• Form: Lyophilized powder
• Storage: -20°C
• Solubility: Sterile water or bacteriostatic water

Disclaimer

For laboratory research use only. Not for human consumption, medical, or veterinary use.

Bourbon Peptides — Research Grade Purity.